SCHEMBL1345970

SCHEMBL1345970

COc1ccc2c(c1)C(Cc1ccccc1F)C(C)C(c1ccc(OC)c(C)c1)C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 1/20 0.39
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
RORC P51449 2/20 0.38
HTR1A P08908 1/20 0.35
HTR7 P34969 1/20 0.35
HTR2B P41595 1/20 0.35
SMO Q99835 1/20 0.35
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 1/20 0.34
HTR2A P28223 2/20 0.34
HTR2C P28335 2/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 2/20 0.34
CYP26A1 O43174 1/20 0.34
CYP24A1 Q07973 1/20 0.34
DRD2 P14416 1/20 0.34
DRD1 P21728 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12133263 0.92 KDM1A (0.40) NQO2MTNR1AMTNR1BRORCHTR1A
SCHEMBL1346637 0.89 NQO2 (0.46) NQO2MTNR1AMTNR1BRORCHTR2A
SCHEMBL1344576 0.84 NQO2 (0.42) NQO2MTNR1AMTNR1BRORCHTR1A
SCHEMBL1346092 0.82 KDM1A (0.40) NQO2MTNR1AMTNR1BRORCHTR1A
SCHEMBL1346987 0.81 TUBB4A (0.36) NQO2MTNR1AMTNR1BRORCKDM4E
SCHEMBL1344496 0.80 NQO2 (0.41) NQO2MTNR1AMTNR1BHTR1AHTR2C
SCHEMBL1344331 0.78 NQO2 (0.44) NQO2MTNR1AMTNR1BHTR2ASLC6A2
SCHEMBL1347021 0.78 SIGMAR1 (0.36) DRD2DRD1MAOB
SCHEMBL1346915 0.78 NQO2 (0.41) NQO2MTNR1AMTNR1BMAOB
SCHEMBL1346589 0.77 NQO2 (0.43) NQO2MTNR1AMTNR1BHTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406206-B1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES MSD OSS BV (NL) 2013-01-30 EP disclosed
US-8063102-B2 Tetrahydronaphthalen-2-ol derivatives N.V. ORGANON (NL) 2011-11-22 US disclosed
US-8063102-B2 Tetrahydronaphthalen-2-ol derivatives N.V. ORGANON (NL) 2011-11-22 US disclosed
US-8063102-B2 Tetrahydronaphthalen-2-ol derivatives N.V. ORGANON (NL) 2011-11-22 US disclosed
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N. V. ORGANON 2010-09-23 US disclosed
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N. V. ORGANON 2010-09-23 US disclosed
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES N. V. ORGANON 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240748-A1 TETRAHYDRONAPHTHALEN-2-OL DERIVATIVES VHL, BRCA1, TPH2 NQO2 1888/4885MTNR1A 133/4885MTNR1B 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.